Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

Kintara Therapeutics to Present at the Planet MicroCap Showcase 2022

Apr 26, 2022

Kintara Announces Closing of $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 14, 2022

Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 12, 2022

Kintara Therapeutics Presents Data at the 2022 American Association for Cancer Research Annual Meeting

Apr 11, 2022

Kintara Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference

Mar 22, 2022

Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting

Mar 15, 2022

Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update

Feb 11, 2022

Kintara Therapeutics to Present at BIO CEO & Investor Conference on February 15, 2022

Feb 4, 2022

Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells

Feb 3, 2022

Kintara Announces Grant from Luxembourg National Research Fund and Cancer Foundation Luxembourg to Support VAL-083's Mechanism of Action Research in Glioblastoma

Jan 12, 2022
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...33
    © 2023 Kintara Therapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences